Isbogrel

N/A

Report date: 2022/05/18 17:42:00
NME

Base Information

Drug NameIsbogrel
Drug Alias Name伊波格雷CV-4151A66900Isbogrel
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsThromboxane A2 receptor antagonists
TargetsThromboxane A2 synthaseThromboxane A2 receptor
Therapy Area/IndicationsThrombosisIschemic Attack, Transient
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombosisIschemic Attack, Transient

Other Information

ATC CodeN/A
Related LinksN/A